Anthony Bergmann Net Worth & Insider Trades

Anthony Bergmann - CHIEF FINANCIAL OFFICER, Capricor Therapeutics, Inc

As of January 4, 2022

What is Anthony Bergmann's Net Worth?

The current estimated net worth of Capricor Therapeutics, Inc's CHIEF FINANCIAL OFFICER, Anthony Bergmann, is estimated to be about $7.25K . Anthony Bergmann owns about 2,030 units of Capricor Therapeutics, Inc common stock. In the last 7 years at Capricor Therapeutics, Inc, Anthony Bergmann has sold an estimated value of $0 worth.

What is Anthony Bergmann's Past Insider Trading?

Anthony Bergmann's largest purchase order was 2,030 units , worth over $4.87K on March 18, 2016. In total, Anthony Bergmann has made about 10 transactions over 7 years of their time at Capricor Therapeutics, Inc. Anthony Bergmann usually trades in January, with the busiest year in 2020 and 2016.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Anthony Bergmann's Salary in 2019?

As CHIEF FINANCIAL OFFICER of Capricor Therapeutics, Inc, Anthony Bergmann has a total base salary of $212,500 . Anthony Bergmann received compensation valued at about $252,827 in 2019 after becoming CHIEF FINANCIAL OFFICER. The vast majority of their compensation came in the form of option awards of $38,827 , and other compensation of $1,500 .

What is Anthony Bergmann's' Mailing Address?

  • Mailing address is C/o Capricor Therapeutics, Inc. 8840 Wilshire Blvd., 2nd Floor Beverly Hills CA 90211 CA

Capricor Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Linda Marbán, Ph.D. 2019 $156,909 - $70,510 $1,500 $228,919
Linda Marbán, Ph.D. 2020 $150,000 $45,000 $1,460,532 $1,500 $1,657,032
Karen Krasney, J.D. 2019 $300,000 - $38,827 $1,500 $340,327
Karen Krasney, J.D. 2020 $313,750 $31,500 $415,855 $1,500 $762,605
Anthony Bergmann 2019 $212,500 - $38,827 $1,500 $252,827
Anthony Bergmann 2020 $287,500 $27,500 $475,692 $1,500 $792,192
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1133869/000110465921052552/tm212634d1_def14a.htm

What are Capricor Therapeutics, Inc's Past Insider Trades?

Capricor Therapeutics, Inc's most recent insider trade came on July 7, 2022 by Xavier Avat who bought 2,500 units worth $9.32K . In the last 7 years, insiders at Capricor Therapeutics, Inc have sold an estimated value of $617.25K and bought an estimated value of $15.83M worth of shares. Insider trading is most common in January, with the busiest year in 2015. The most active traders at the company are Louis Manzo,  David Musket,  and Karen Krasney, EVP .

CAPRICOR THERAPEUTICS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1